As an example, in patients with obesity, PCSK9 has a key role on the release of EVs-derived from different atherosclerotic components (i.e., platelets, monocytes/macrophages, endothelium, and neutrophils) and EVs-derived miRNA linked to inflammation and atherosclerosis (112). This evidence concerns the gene PCSK9 and atherosclerosis.